BioBeats Revenue and Competitors
Estimated Revenue & Valuation
- BioBeats's estimated annual revenue is currently $675k per year.
- BioBeats's estimated revenue per employee is $135,000
Employee Data
- BioBeats has 5 Employees.
- BioBeats grew their employee count by -17% last year.
BioBeats's People
| Name | Title | Email/Phone |
|---|
BioBeats Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $25.1M | 93 | -3% | N/A | N/A |
#2 | $35.6M | 132 | 3% | N/A | N/A |
#3 | $61.5M | 207 | 5% | N/A | N/A |
#4 | N/A | 0 | N/A | N/A | N/A |
#5 | $23M | 85 | -19% | £8.2M | N/A |
#6 | $7.1M | 33 | -8% | N/A | N/A |
#7 | $17.7M | 73 | -4% | N/A | N/A |
#8 | $150.5M | 446 | 9% | N/A | N/A |
#9 | $159.3M | 472 | 5% | N/A | N/A |
#10 | $122.9M | 364 | 6% | N/A | N/A |
What Is BioBeats?
We create digital products that change the way people look at, deal with and take control of their wellbeing. Through listening to and harnessing artificial intelligence, user data and human insight, we provide an ever-improving cycle of evidence-based interventions, by finding patterns that link stress to health risks and physical outcomes.
keywords:N/A
N/A
Total Funding
5
Number of Employees
$675k
Revenue (est)
-17%
Employee Growth %
N/A
Valuation
N/A
Accelerator
BioBeats News
... Microsoft, Sony, Garmin, Fitbit, Huawei, Amazon, IBM, Oracle, Bragi, Motive, Shft, Lifebeam, Focusmotion, Moov, Atlas, Biobeats, Physiq & Touchkin etc.
Bluebird Bio Beats Investors' Sickle Cell Therapy Timeline Suit. By Jennifer Bennett. April 22, 2022, 8:36 PM. Facts alleged show company disclosed relevant...
Biobeat is a med-tech company with unique health-AI capabilities in the patient monitoring space. The company's remote patient monitoring (RPM)...
Other Companies in London
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.4M | 5 | 0% | $7M |
#2 | $0.4M | 5 | -37% | N/A |
#3 | $0.6M | 5 | -37% | N/A |
#4 | $0.4M | 5 | -58% | N/A |
#5 | $0.3M | 5 | -17% | N/A |